FLJ36644 inhibitors refer to a class of chemical compounds that target the protein encoded by the *FLJ36644* gene, which is associated with various cellular pathways. These inhibitors function by interacting with the structure or active sites of the protein, thereby modulating its activity within the cell. *FLJ36644* is a gene of interest due to its role in regulating intracellular processes such as signal transduction, gene expression, or protein-protein interactions. By inhibiting the protein product of this gene, the associated compounds aim to disrupt its normal function, which could lead to altered cell behavior. The inhibitors often possess specific structural features that allow them to bind selectively to the target protein, preventing it from carrying out its typical biological functions.
The development and study of FLJ36644 inhibitors often focus on the specificity and potency of these compounds in modulating the targeted protein's function. Their design typically involves high-throughput screening or rational drug design approaches, with the goal of identifying molecules that can effectively bind to the protein of interest with minimal off-target effects. Chemical properties such as solubility, stability, and binding affinity are critical in determining the efficacy of FLJ36644 inhibitors. Understanding the structural and biochemical characteristics of these inhibitors helps to elucidate how they interact with the target protein and their potential impact on cellular processes. The inhibitors may also undergo structural modifications to enhance their binding efficiency and selectivity toward the *FLJ36644*-encoded protein.
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
A multikinase inhibitor, potentially disrupting various kinase-regulated pathways including those associated with FLJ36644. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Inhibits BCR-ABL, c-Kit, and PDGFR, potentially affecting pathways that involve FLJ36644. | ||||||